NI
Neurogene Inc
🇺🇸XNAS.NGNEUnited StatesHealthcare
$34.52USDup +0.84 (+2.49%)After-hoursDelayed8:11 PM
Price$34.52+0.84 (+2.49%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US64135M1053
- CUSIP
- 64135M105
Company
- Employees
- 131
- Headquarters
- New York, United States
- Website
- https://www.neurogene.com
- CEO
- Dr. Rachel L. McMinn Ph.D.
Market
- Shares outstanding
- 20M
- Market cap
- $690.79M
Highlights
- Market cap
- $675.78M
- EPS LTM
- -$4.93
- P/E LTM
- -6.45
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0+100%up year on year
- Net income
- -$111.11M-31.66%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$87.11M-16.92%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.